IRIS Accounts Production v25.1.3.33 03039630 Board of Directors 31.3.23 29.9.24 29.9.24 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh030396302023-03-30030396302024-09-29030396302023-03-312024-09-29030396302022-03-30030396302022-03-312023-03-30030396302023-03-3003039630ns15:EnglandWales2023-03-312024-09-2903039630ns14:PoundSterling2023-03-312024-09-2903039630ns10:Director12023-03-312024-09-2903039630ns10:PrivateLimitedCompanyLtd2023-03-312024-09-2903039630ns10:SmallEntities2023-03-312024-09-2903039630ns10:AuditExempt-NoAccountantsReport2023-03-312024-09-2903039630ns10:SmallCompaniesRegimeForDirectorsReport2023-03-312024-09-2903039630ns10:SmallCompaniesRegimeForAccounts2023-03-312024-09-2903039630ns10:FullAccounts2023-03-312024-09-2903039630ns10:OrdinaryShareClass12023-03-312024-09-2903039630ns10:Director22023-03-312024-09-2903039630ns10:RegisteredOffice2023-03-312024-09-2903039630ns5:CurrentFinancialInstruments2024-09-2903039630ns5:CurrentFinancialInstruments2023-03-3003039630ns5:ShareCapital2024-09-2903039630ns5:ShareCapital2023-03-3003039630ns5:RetainedEarningsAccumulatedLosses2024-09-2903039630ns5:RetainedEarningsAccumulatedLosses2023-03-3003039630ns5:PlantMachinery2023-03-312024-09-2903039630ns5:PlantMachinery2023-03-3003039630ns5:PlantMachinery2024-09-2903039630ns5:PlantMachinery2023-03-3003039630ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-2903039630ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3003039630ns10:OrdinaryShareClass12024-09-29
REGISTERED NUMBER: 03039630 (England and Wales)




UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

31 MARCH 2023 TO 29 SEPTEMBER 2024

FOR

EUROPEAN VETERINARY SUPPLIES LIMITED

EUROPEAN VETERINARY SUPPLIES LIMITED (REGISTERED NUMBER: 03039630)






CONTENTS OF THE FINANCIAL STATEMENTS
for the period 31 March 2023 to 29 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


EUROPEAN VETERINARY SUPPLIES LIMITED

COMPANY INFORMATION
for the period 31 March 2023 to 29 September 2024







DIRECTORS: Mrs S E Taylor
L D Taylor





REGISTERED OFFICE: Unit 2
Bosworth Avenue
Tournament Fields
Warwick
Warwickshire
CV34 6UQ





REGISTERED NUMBER: 03039630 (England and Wales)





ACCOUNTANTS: LDP Luckmans
1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB

EUROPEAN VETERINARY SUPPLIES LIMITED (REGISTERED NUMBER: 03039630)

BALANCE SHEET
29 September 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 3 3

CURRENT ASSETS
Stocks 68,595 214,665
Debtors 5 908,160 255,878
Cash at bank 348,619 293,853
1,325,374 764,396
CREDITORS
Amounts falling due within one year 6 827,174 354,948
NET CURRENT ASSETS 498,200 409,448
TOTAL ASSETS LESS CURRENT
LIABILITIES

498,203

409,451

CAPITAL AND RESERVES
Called up share capital 7 250,000 250,000
Retained earnings 248,203 159,451
SHAREHOLDERS' FUNDS 498,203 409,451

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 29 September 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 29 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 June 2025 and were signed on its behalf by:





L D Taylor - Director


EUROPEAN VETERINARY SUPPLIES LIMITED (REGISTERED NUMBER: 03039630)

NOTES TO THE FINANCIAL STATEMENTS
for the period 31 March 2023 to 29 September 2024

1. STATUTORY INFORMATION

European Veterinary Supplies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.


EUROPEAN VETERINARY SUPPLIES LIMITED (REGISTERED NUMBER: 03039630)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the period 31 March 2023 to 29 September 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2023 - 2 ).

4. TANGIBLE FIXED ASSETS
Plant and
machinery
£   
COST
At 31 March 2023
and 29 September 2024 18,764
DEPRECIATION
At 31 March 2023
and 29 September 2024 18,761
NET BOOK VALUE
At 29 September 2024 3
At 30 March 2023 3

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 882,349 228,632
Amounts owed by group undertakings 5,516 4,886
Amounts owed by participating interests 7,385 3,947
Other debtors 11,388 18,081
Prepayments and accrued income 1,522 332
908,160 255,878

EUROPEAN VETERINARY SUPPLIES LIMITED (REGISTERED NUMBER: 03039630)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the period 31 March 2023 to 29 September 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 701,263 152,687
Amounts owed to group undertakings 109,837 182,274
VAT 11,568 11,735
Other creditors 92 92
Accrued expenses 4,414 8,160
827,174 354,948

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
250,000 Ordinary £1 250,000 250,000

8. FINANCIAL COMMITMENTS, GUARANTEES AND CONTINGENT LIABILITIES

The company is party to a multilateral guarantee given by European Veterinary Supplies Limited, Manx Healthcare Limited and Richard's Pharma Limited in favour of HSBC Bank PLC, whose interest is secured by way of a fixed and floating charge.

9. PARENT COMPANY

European Veterinary Supplies Limited is a wholly owned subsidiary of Richard's Pharma Limited and the ultimate parent company is Richard's Pharma (Holdings) Limited, a company registered in England and Wales,Unit 2, Bosworth Avenue, Tournament Fields, Warwick, CV34 6UQ.